Golounina O O, Belaya Zh/ E, Rozhinskaya L Ya, Pikunov M Yu, Markovich A A, Dzeranova L K, Marova E I, Kuznetsov N S, Fadeev V V, Melnichenko G A, Dedov I I
I.M. Sechenov First Moscow State Medical University (Sechenov University).
Endocrinology Research Centre.
Probl Endokrinol (Mosk). 2022 Aug 15;68(6):30-42. doi: 10.14341/probl13144.
To determine significant factors affecting the survival of patients with ectopic ACTH syndrome (EAS).
A multi-center, observational study with a retrospective analysis of patients with EAS. The end point of the study was the fatal outcome of patients from various causes. In order to identify predictors of survival or mortality, univariate and multifactorial Cox regression analyses were carried out. ROC-analysis was used to determine the prognostic threshold values of individual predictors. The survival analysis was carried out using the Kaplan-Mayer method. Statistical data processing was carried out by using IBM SPSS Statistics 23.
The age of patients at the time of diagnosis ranged from 12 to 76 years (Me 40 years [28;54]). The age of the studied population was 55 years [38; 64] for women and 42 years [32; 54] for men. The median period of observation was 50 months [13;91], with a maximum follow-up of 382 months. 92 patients (60,9%) had bronchopulmonary NET, 17 (11,3%) - thymic carcinoid, 8 - pancreatic NET, 5 -pheochromocytoma, 1- cecum NET, 1- appendix carcinoid tumor, 1 - medullary thyroid cancer and 26 (17,2%) patients had an occult NET. The primary tumor was removed in 101 patients (66,9%). Bilateral adrenalectomy was performed in 42 (27,8%) cases. Metastases were revealed in 23,2% (n=35) of patients. Relapse of the disease was observed in 24,4%, long-term remission was preserved in 64 patients (74,4%). Death occurred in 42 patients (28%). The average age of survivors was 47,0±15,2 versus 53,5±15,6 years for the deceased (p=0,022). The average survival time from diagnosis for the deceased was 32 months, Me 16,5 months [7;54]. Multivariate analysis revealed that the following factors have a direct impact on survival: age of diagnosis ≥51 years (OR 4,493; 95% CI 2,056-9,818, p<0,001), bronchopulmonary neuroendocrine tumor (NET) (OR 0,281; 95% CI 0,119-0,665, p=0,004), the presence of distant metastases (OR 2,489; 95% CI 1,141-5,427, p=0,022), late-night salivary cortisol (LNSC) ≥122,2 nmol/L (OR 2,493; 95% CI 1,014-6,128, p=0,047).
The prognosis of patients with EAS is influenced by the age of diagnosis, NET localization, distant metastases and level of LNSC. The most common cause of ectopic ACTH syndrome was bronchopulmonary NET which was associated with the best survival rate.
确定影响异位促肾上腺皮质激素综合征(EAS)患者生存的重要因素。
一项多中心观察性研究,对EAS患者进行回顾性分析。研究的终点是患者因各种原因导致的死亡结局。为了确定生存或死亡的预测因素,进行了单因素和多因素Cox回归分析。采用ROC分析确定各预测因素的预后阈值。使用Kaplan - Mayer方法进行生存分析。使用IBM SPSS Statistics 23进行统计数据处理。
诊断时患者年龄在12至76岁之间(中位数40岁[28;54])。研究人群中女性年龄为55岁[38;64],男性为42岁[32;54]。中位观察期为50个月[13;91],最长随访时间为382个月。92例患者(60.9%)患有支气管肺神经内分泌肿瘤(NET),17例(11.3%)为胸腺类癌,8例为胰腺NET,5例为嗜铬细胞瘤,1例为盲肠NET,1例为阑尾类癌肿瘤,1例为甲状腺髓样癌,26例(17.2%)患者患有隐匿性NET。101例患者(66.9%)切除了原发肿瘤。42例(27.8%)患者进行了双侧肾上腺切除术。23.2%(n = 35)的患者发现有转移。24.4%的患者出现疾病复发,64例患者(74.4%)保持长期缓解。42例患者(28%)死亡。幸存者的平均年龄为47.0±15.2岁,而死亡者为53.5±15.6岁(p = 0.022)。从诊断到死亡的平均生存时间为32个月,中位数为16.5个月[7;54]。多因素分析显示,以下因素对生存有直接影响:诊断年龄≥51岁(OR 4.493;95% CI 2.056 - 9.818,p<0.001)、支气管肺神经内分泌肿瘤(NET)(OR 0.281;95% CI 0.119 - 0.665,p = 0.004)、存在远处转移(OR 2.489;95% CI 1.141 - 5.427,p = 0.022)、午夜唾液皮质醇(LNSC)≥122.2 nmol/L(OR 2.493;95% CI 1.014 - 6.128,p = 0.047)。
EAS患者的预后受诊断年龄、NET定位、远处转移和LNSC水平影响。异位促肾上腺皮质激素综合征最常见的病因是支气管肺NET,其生存率最佳。